The Exeter to end Managed Life offering

Latest simplification of insurer's proposition

clock • 1 min read

The Exeter will soon offer life cover to those with Type 2 diabetes and high BMI through its Real Life proposition as it winds down the Managed Life product.

The move is part of a "simplification" of the insurer's life cover offering, following adviser feedback which emphasised customers' preference for "certainty and simplicity of guaranteed premiums." From 30 September, the insurer's Managed Life product for customers with Type 2 diabetes or a high BMI, which offered variable premiums based on management of a customer's health, will cease to be available. Applicants with these conditions will instead be covered by its Real Life proposition instead. Steve Bryan, director of distribution and marketing at the Exeter, said: "By simplifying o...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Individual Protection

Quarter of over-55s have informed executors on how to locate protection policies

Quarter of over-55s have informed executors on how to locate protection policies

Canada Life research findings

Jaskeet Briah
clock 11 September 2026 • 2 min read
Sorry (not sorry) to interrupt

Sorry (not sorry) to interrupt

World Suicide Prevention Day

Cameron Roberts
clock 10 September 2026 • 3 min read
Over half of parents financially impacted by their child's illness or injury

Over half of parents financially impacted by their child's illness or injury

MetLife’s Everyday Risk Report

Jaskeet Briah
clock 09 September 2026 • 2 min read